Please Note: Microsoft has ended support of its older browsers as of January 2016. If you are seeing this message, you are viewing the site on an unsupported version of Internet Explorer (IE10 or older). To properly view this website, please upgrade your version of IE or access this site using a different browser. Thank you.
Sign InDues Join Privacy Contact Search
Home News APCR Comments on Proposed Executive Order on International Reference Pricing

News

APCR Comments on Proposed Executive Order on International Reference Pricing

posted: August 7, 2020

In August 7, 2020, correspondence with Health and Human Services Secretary Alex Azar, the APCR commented on the pending Executive Order on international reference pricing for drugs purchased through Medicare. The letter signed by APCR President Dr. Lyndon Mansfield concludes:

While we truly appreciate the Administration’s commitment to finding solutions that will make prescription drugs affordable for Americans, reference pricing alone cannot guarantee our research enterprise will remain competitive in drug innovation. We need policies that will ensure America’s long-term leadership both in developing new drugs and in making them affordable for patients. We hope to work together with policymakers and health care stakeholders to find a better solution for all.

Download Full Letter